Ironwood Pharmaceuticals (IRWD) Asset Utilization Ratio (2011 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Asset Utilization Ratio of 0.87 for Q1 2026, up 16.42% sequentially from 0.75 in Q4 2025, and down 7.19% YoY from 0.94 in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Asset Utilization Ratio for 16 years, with the latest figure at 0.87 in Q1 2026.
- Quarterly Asset Utilization Ratio fell 7.19% year-over-year to 0.87 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.87 (down 7.19% YoY) and the FY2025 annual result came in at 0.79, down 7.37% from the prior year.
- Asset Utilization Ratio advanced to 0.87 in Q1 2026 per IRWD's latest filing, from 0.75 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.96 in Q3 2024 and troughed at 0.37 in Q1 2023.
- A 5-year average of 0.72 and a median of 0.87 in 2026 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio slumped 44.42% in 2022, then surged 145.79% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.38 in 2022, then soared by 131.97% to 0.89 in 2023, then increased by 6.68% to 0.95 in 2024, then slipped by 21.31% to 0.75 in 2025, then grew by 16.42% to 0.87 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.87, 0.75, and 0.92 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 706.94 Mn | 627.81 Mn | - | 1.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.08 |
| Mar 31, 2026 | 0.87 |
| Dec 31, 2025 | 0.75 |
| Sep 30, 2025 | 0.92 |
| Jun 30, 2025 | 0.92 |
| Mar 31, 2025 | 0.94 |
| Dec 31, 2024 | 0.95 |
| Sep 30, 2024 | 0.96 |
| Jun 30, 2024 | 0.96 |
| Mar 31, 2024 | 0.91 |
| Dec 31, 2023 | 0.89 |
| Sep 30, 2023 | 0.77 |
| Jun 30, 2023 | 0.49 |
| Mar 31, 2023 | 0.37 |
| Dec 31, 2022 | 0.38 |
| Sep 30, 2022 | 0.42 |
| Jun 30, 2022 | 0.40 |
| Mar 31, 2022 | 0.38 |
| Dec 31, 2021 | 0.38 |
| Sep 30, 2021 | 0.40 |